强的松
胸腺切除术
医学
重症肌无力
胸腺瘤
随机对照试验
皮质类固醇
外科
内科学
胃肠病学
作者
Ik Jae Lee,Hui‐Chien Kuo,Inmaculada Aban,Gary Cutter,Tarrant McPherson,Henry J. Kaminski,Jon D. Sussman,Philipp Ströbel,Joel J.-F. Oger,Gabriel Cea,Jeannine M. Heckmann,Amelia Evoli,Wilfred A. Nix,Emma Ciafaloni,Giovanni Antonini,Rawiphan Witoonpanich,John O King,Said R. Beydoun,Colin Chalk,Alexandru C. Barboi
出处
期刊:Neurology
[Lippincott Williams & Wilkins]
日期:2020-07-01
卷期号:95 (6): e755-e766
被引量:36
标识
DOI:10.1212/wnl.0000000000010031
摘要
OBJECTIVE: To examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG). METHODS: This study is a post hoc analysis of data from a randomized trial of thymectomy in MG (Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy [MGTX]). MGTX was a multicenter, randomized, rater-blinded 3-year trial that was followed by a voluntary 2-year extension for patients with acetylcholine receptor (AChR) antibody-positive MG without thymoma. Patients were randomized 1:1 to thymectomy plus prednisone vs prednisone alone. Participants were age 18-65 years at enrollment with disease duration less than 5 years. All patients received oral prednisone titrated up to 100 mg on alternate days until they achieved MMS, which prompted a standardized prednisone taper as long as MMS was maintained. The achievement rate of sustained MMS (no symptoms of MG for 6 months) with complete withdrawal of prednisone was compared between the thymectomy plus prednisone and prednisone alone groups. RESULTS: < 0.001) over the 5-year study period. Prednisone-associated adverse symptoms were more frequent in the prednisone alone group and distress level increased with higher doses of prednisone. CONCLUSIONS: Thymectomy benefits patients with MG by increasing the likelihood of achieving sustained MMS with complete withdrawal of prednisone. CLINICALTRIALSGOV IDENTIFIER: NCT00294658. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for patients with generalized MG with AChR antibody, those receiving thymectomy plus prednisone are more likely to attain sustained MMS and complete prednisone withdrawal than those on prednisone alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI